SCHEMBL492464

SCHEMBL492464

CN(C)C(c1cccs1)C1CCC(NC(=O)COCCN(Cc2ccccc2)S(=O)(=O)c2ccccc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
BMP1 P13497 1/20 0.37
CCR5 P51681 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
CXCR3 P49682 2/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
SLC6A4 P31645 1/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TAS2R14 Q9NYV8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL493169 0.89 CXCR3 (0.43) LMNAMEN1KMT2ABMP1CXCR3
SCHEMBL493051 0.89 NPSR1 (0.41) NPSR1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL492680 0.88 KMT2A (0.41) NPSR1LMNAMEN1KMT2ABMP1
SCHEMBL492677 0.85 TAS2R14 (0.41) NPSR1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL493377 0.83 NPSR1 (0.42) NPSR1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL493420 0.83 LMNA (0.38) LMNASMN1; SMN2TDP1MAPTALDH1A1
SCHEMBL493632 0.83 LMNA (0.37) LMNASMN1; SMN2MEN1KMT2ACCR5
SCHEMBL492541 0.82 ALDH1A1 (0.45) NPSR1LMNAKMT2ATDP1L3MBTL1
SCHEMBL493028 0.79 L3MBTL1 (0.42) NPSR1LMNASMN1; SMN2HTR2AMAPT
SCHEMBL492994 0.79 PKM (0.43) MEN1KMT2ACCR5MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD NPSR1 371/4885LMNA 2485/4885SMN1; SMN2 1729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.